Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine

Stephanie J. Weinstein, Terryl J. Hartman, Rachael Stolzenberg-Solomon, Pirjo Pietinen, Michael J. Barrett, Philip R. Taylor, Jarmo Virtamo and Demetrius Albanes
Stephanie J. Weinstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terryl J. Hartman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachael Stolzenberg-Solomon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pirjo Pietinen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Barrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip R. Taylor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarmo Virtamo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Demetrius Albanes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Introduction

Folate is necessary for DNA synthesis, repair, and methylation, and biological reactions involving folate require vitamins B6 and B12 as cofactors. Low concentrations of these vitamins can impair one-carbon metabolism pathways (1) , leading to homocysteine accumulation, insufficient methyl groups for DNA methylation, or depletion of DNA synthesis and repair precursors, thus, potentially promoting carcinogenesis (2) . These nutrients have been implicated with respect to several malignancies, including colorectum, lung, and cervix (3) , and may impact prostate cancer (4) . Both hyper- and hypomethylated DNA have been found in prostate tumors (4) , and the activation of estrogen receptors in prostate cancer cell lines and tissues is regulated through promoter region methylation (5) . We examined whether high serum folate, vitamin B6, or vitamin B12 or low serum homocysteine was associated with decreased prostate cancer risk.

Materials and Methods

The ATBC6 Study (6) included 29,133 male smokers, ages 50–69 years, recruited from southwestern Finland from 1985 to 1988. Subjects were provided α-tocopherol and/or β-carotene supplements or placebo for 5–8 years, with postintervention follow-up continuing through the Finnish Cancer Registry. The study was approved by the institutional review boards of the National Cancer Institute and the National Public Health Institute of Finland. Cases were defined as incident prostate cancers diagnosed through 1994 with available serum (n = 232). Two controls were matched to each case based on clinic, intervention group, date of baseline blood draw (±45 days), age (±5 years), and serum availability (n = 464). At baseline, participants completed detailed dietary questionnaires and provided fasting serum samples (stored at −70°C), which were analyzed as described (7) . Cases and matched controls were assayed consecutively within batches. Coefficients of variation, calculated from masked quality-control samples, were 9% (folate), 6% (B12), and 15% (B6 and homocysteine). ORs and 95% CIs were estimated using conditional logistic regression models, adjusted for BPH at baseline (with no other confounders identified). Effect modification was assessed through a cross-product term and stratification. We had 88% power to detect an OR of ≥2.0 for the highest versus lowest quartile (α = 0.05).

Results

Prostate cancer cases reported greater use of vitamin/mineral supplements than did controls, but cases did not differ with respect to other demographic, dietary, and serum factors examined. Many subjects had inadequate serum vitamin status (92% for folate, with 24% deficient; 55% for B6; and 1% for B12), and 19% had mildly elevated homocysteine. Correlations between nutrient intakes and serum concentrations were modest; for folate, B6, and B12, Spearman r values were 0.20, 0.33, and 0.13, respectively. Homocysteine was inversely correlated with folate, B6, and B12 (r values: −0.40, −0.12, and −0.19, respectively).

Serum folate, B6, B12, and homocysteine were not associated with prostate cancer risk (Table 1)⇓ . There was no evidence of effect modification by age, intervention group, smoking, body mass index, BPH, or intake of folate, B6, B12, or methionine; however, the association between homocysteine and prostate cancer risk was modified significantly by alcohol intake (p interaction = 0.04), with a positive association observed among those who consumed more alcohol (OR = 1.71 and 95% CI = 0.76–3.83 for highest versus lowest quartile) and a modest inverse association among those who consumed less alcohol. Consistent with this, an opposite pattern was observed for serum folate (interaction not significant). We observed no material differences in the associations based on disease stage.

View this table:
  • View inline
  • View popup
Table 1

Adjusted ORs and 95% CIs of prostate cancer by baseline serum nutrient quartiles (ATBC Study, 1985–1994)

Discussion

We observed no association between serum factors related to one-carbon metabolism and prostate cancer risk, although these relationships may be modified by alcohol intake. Smoking has been inversely associated with folate status, and all enrollees in the ATBC Study smoked ≥5 cigarettes/day at baseline; however, other investigations from this cohort showed inverse associations for these one-carbon factors (e.g., pancreas and lung cancers). Whether smokers may benefit from these nutrients for only selected cancers, and whether individuals with high alcohol intakes have increased requirements for folate and one-carbon metabolism cofactors, should be pursued in other studies.

The prospective study design is an important strength that minimized the possibility of disease or treatment effects on serum, and we examined several key serum factors related to one-carbon metabolism. The study included only older male smokers who participated in the original prevention trial, limiting the generalizability of the present study. Furthermore, study subjects had relatively low concentrations of folate and B6, a strength when compared with studies not capturing well the low serum range, but a potential limitation if higher concentrations are essential for cancer risk reduction. In conclusion, although one-carbon metabolism factors may be associated with the risk of several malignancies (3) , the factors do not seem to be related to prostate cancer in this study.

Acknowledgments

We thank Dr. Jacob Selhub of Tufts University for conducting the serum assays.

Footnotes

  • Grant support: Public Health Service Contracts N01-CN45165 and N01-RC45035 from the National Cancer Institute, Department of Health and Human Services.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Requests for reprints: Stephanie Weinstein, Nutritional Epidemiology Branch, DCEG, National Cancer Institute, 6120 Executive Boulevard, Suite 320, Bethesda, MD 20892. E-mail: weinstes{at}mail.nih.gov

  • ↵6 The abbreviations used are: ATBC, Alpha-Tocopherol Beta-Carotene Cancer Prevention; OR, odds ratio; CI, confidence interval; BPH, benign prostatic hyperplasia.

  • Received May 21, 2003.
  • Revision received June 11, 2003.
  • Accepted July 28, 2003.

References

  1. ↵
    Selhub J. Homocysteine metabolism. Annu. Rev. Nutr., 19: 217-246, 1999.
    OpenUrlCrossRefPubMed
  2. ↵
    Eto I., Krumdieck C. L. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv. Exp. Med. Biol., 206: 313-330, 1986.
    OpenUrlPubMed
  3. ↵
    Glynn S. A., Albanes D. Folate and cancer: a review of the literature. Nutr. Cancer, 22: 101-119, 1994.
    OpenUrlPubMed
  4. ↵
    Schulz W. A. DNA methylation in urological malignancies (Review). Int. J. Oncol., 13: 151-167, 1998.
    OpenUrlPubMed
  5. ↵
    Sasaki M., Tanaka Y., Perinchery G., Dharia A., Kotcherguina I., Fujimoto S., Dahiya R. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J. Natl. Cancer Inst., 94: 384-390, 2002.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann. Epidemiol., 4: 1-10, 1994.
    OpenUrlPubMed
  7. ↵
    Stolzenberg-Solomon R. Z., Albanes D., Nieto F. J., Hartman T. J., Tangrea J. A., Rautalahti M., Selhub J., Virtamo J., Taylor P. R. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J. Natl. Cancer Inst., 91: 535-541, 1999.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 12 (11)
November 2003
Volume 12, Issue 11
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine
Stephanie J. Weinstein, Terryl J. Hartman, Rachael Stolzenberg-Solomon, Pirjo Pietinen, Michael J. Barrett, Philip R. Taylor, Jarmo Virtamo and Demetrius Albanes
Cancer Epidemiol Biomarkers Prev November 1 2003 (12) (11) 1271-1272;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Null Association between Prostate Cancer and Serum Folate, Vitamin B6, Vitamin B12, and Homocysteine
Stephanie J. Weinstein, Terryl J. Hartman, Rachael Stolzenberg-Solomon, Pirjo Pietinen, Michael J. Barrett, Philip R. Taylor, Jarmo Virtamo and Demetrius Albanes
Cancer Epidemiol Biomarkers Prev November 1 2003 (12) (11) 1271-1272;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement